Published in J Invest Dermatol on January 01, 1995
Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48
Host DNA can interfere with detection of Borrelia burgdorferi in skin biopsy specimens by PCR. J Clin Microbiol (1996) 1.27
PCR in laboratory diagnosis of human Borrelia burgdorferi infections. Clin Microbiol Rev (1997) 1.23
Diagnostic value of PCR for detection of Borrelia burgdorferi in skin biopsy and urine samples from patients with skin borreliosis. J Clin Microbiol (1998) 1.05
Sensitive detection of Borrelia burgdorferi sensu lato DNA and differentiation of Borrelia species by LightCycler PCR. J Clin Microbiol (2001) 0.92
Morphoea and Borrelia burgdorferi: results from the Scottish Highlands in the context of the world literature. Mol Pathol (2002) 0.79
Frequency of Borrelia in Morphea Lesion by Polymerase Chain Reaction in Northeast of Iran. Jundishapur J Microbiol (2015) 0.75
Morphea and Eosinophilic Fasciitis: An Update. Am J Clin Dermatol (2017) 0.75
Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst (1996) 1.79
Identification and characterization of 20 immunocompetent patients with simultaneous varicella zoster and herpes simplex virus infection. J Eur Acad Dermatol Venereol (2008) 1.52
Aetiology of tuberculids. Lancet (1993) 1.45
Garin-Bujadoux-Bannwarth syndrome. Lancet (1990) 1.43
p53 protein in benign and malignant sweat gland tumors. Am J Dermatopathol (1994) 1.42
In situ localization of IgG in epidermolysis bullosa acquisita by immunogold technique. J Am Acad Dermatol (1992) 1.40
[Virus-specific antibody profile in various stages of HIV-1 infection. Western blot analysis of 170 patients]. Klin Wochenschr (1988) 1.38
Validation of Dermaphot(®) for the assessment of steroid-induced skin atrophy. Arch Dermatol Res (2012) 1.38
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32
Quantitation of thymidylate synthase, dihydrofolate reductase, and DT-diaphorase gene expression in human tumors using the polymerase chain reaction. Cancer Res (1992) 1.27
UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol (2001) 1.25
Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol (1998) 1.25
T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol (1994) 1.23
Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med (1996) 1.22
Binding to human jejunum of serum IgA antibody from children with coeliac disease. Lancet (1990) 1.22
Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion. Ann Oncol (2010) 1.20
Molecular subtyping of Borrelia burgdorferi in erythema migrans and acrodermatitis chronica atrophicans. J Invest Dermatol (1994) 1.16
Oral pemphigus vulgaris. A report of ten cases. Arch Dermatol (1977) 1.14
Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials. Br J Dermatol (2008) 1.14
Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour. Br J Dermatol (1999) 1.14
Immunogenetic associations of scleroderma-related antinuclear antibodies. Arthritis Rheum (1990) 1.14
Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1. Dermatology (2009) 1.11
Loss of tuberin, the tuberous-sclerosis-complex-2 gene product is associated with angiogenesis. J Cutan Pathol (2001) 1.11
Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis. Lancet (1991) 1.11
Reinfection with Borrelia burgdorferi. Lancet (1986) 1.10
Systemic scleroderma. Clinical and pathophysiologic aspects. J Am Acad Dermatol (1988) 1.09
[Isolation of penicillinase forming gonococci in Munich]. MMW Munch Med Wochenschr (1978) 1.07
Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease. J Clin Microbiol (1998) 1.06
Microbiological findings in erythema (chronicum) migrans and related disorders. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 1.05
Borrelia burgdorferi myositis: report of eight patients. J Neurol (1993) 1.05
Molecular detection of Borrelia burgdorferi in formalin-fixed, paraffin-embedded lesions of Lyme disease. J Cutan Pathol (1993) 1.05
Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol (2001) 1.04
Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum (1979) 1.04
Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma. J Cutan Pathol (2007) 1.02
Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors. Br J Dermatol (2009) 1.01
Autoantibodies to C-reactive protein (CRP) and other acute-phase proteins in systemic autoimmune diseases. Clin Exp Immunol (1998) 1.01
Myositis caused by Borrelia burgdorferi: report of four cases. J Neurol Sci (1989) 1.01
Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol (1997) 1.01
Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register. Rheumatology (Oxford) (2009) 1.01
Cyclosporin in the treatment of patients with atopic eczema - a systematic review and meta-analysis. J Eur Acad Dermatol Venereol (2007) 1.01
Ultrastructural binding sites of endomysium antibodies from sera of patients with dermatitis herpetiformis and coeliac disease. Gut (1992) 1.00
Risk and protective factors for sporadic basal cell carcinoma: results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol (2004) 0.99
Cross immunity among types of Borrelia burgdorferi. Lancet (1993) 0.96
Mutational analysis of human NRAS genes in malignant melanoma: rapid methods for oligonucleotide hybridization and manual and automated direct sequencing of products generated by the polymerase chain reaction. Genes Chromosomes Cancer (1990) 0.96
The emigration of Germany's Jewish dermatologists in the period of National Socialism. J Eur Acad Dermatol Venereol (2003) 0.95
Elevated pretreatment serum levels of soluble vascular cell adhesion molecule 1 and lactate dehydrogenase as predictors of survival in cutaneous metastatic malignant melanoma. Br J Cancer (1998) 0.95
Sensitivity of Neisseria gonorrhoeae to penicillin in West Germany. Br J Vener Dis (1979) 0.95
Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation. Proc Natl Acad Sci U S A (1993) 0.94
Elevated serum levels of S100 and survival in metastatic malignant melanoma. Br J Cancer (1997) 0.94
Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus. Br J Dermatol (2006) 0.93
[Pachydermoperiostosis]. Hautarzt (1995) 0.93
Demonstration of UVB-induced synthesis of 1 alpha,25-dihydroxyvitamin D3 (calcitriol) in human skin by microdialysis. Arch Dermatol Res (2003) 0.92
Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association. Br J Dermatol (1996) 0.92
Treatment of localised scleroderma by UVA1 phototherapy. Lancet (1995) 0.92
Late metastases of cutaneous melanoma: an analysis of 31 patients. J Am Acad Dermatol (2000) 0.91
Overexpression of p53 protein in basal cell carcinomas of human skin. Am J Pathol (1992) 0.91
Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s). Nucleic Acids Res (1992) 0.90
Preputial abscesses caused by beta-lactamase-producing gonococci. Cutis (1985) 0.90
Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 in human skin equivalents. Exp Dermatol (2000) 0.89
Reinfection in erythema migrans disease. Infection (1986) 0.89
Factors associated with a high tumour thickness in patients with melanoma. Br J Dermatol (2007) 0.89
Cytological diagnosis of zosteriform skin metastases in undiagnosed breast carcinoma. Br J Dermatol (1996) 0.89
Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents--a preliminary study. Arch Dermatol Res (1999) 0.88
Comparison of three methods to detect white blood cells in semen: leukocyte esterase dipstick test, granulocyte elastase enzymeimmunoassay, and peroxidase cytochemistry. Fertil Steril (1992) 0.88
Antibiotic therapy in early erythema migrans disease and related disorders. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.88
Adherence of Escherichia coli to sperm: a mannose mediated phenomenon leading to agglutination of sperm and E. coli. Fertil Steril (1993) 0.87
Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study. Br J Dermatol (2007) 0.87
PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients. Arch Dermatol (1996) 0.87
[Fast and efficient healing of scleroderma-associated acral ulcers with sildenafil]. Hautarzt (2008) 0.86
A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis. Infection (1990) 0.86
Repeated exposition to subinhibitory concentrations of antibiotic in vitro readily decreases susceptibility of Neisseria gonorrhoeae to rifampicin, but not to new cephalosporins and penicillin G. Chemotherapy (1984) 0.86
Sequence analysis of a human gene responsible for drug resistance: a rapid method for manual and automated direct sequencing of products generated by the polymerase chain reaction. Biotechniques (1989) 0.86
Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicans. Ann N Y Acad Sci (1988) 0.86
Detection of mycobacterial DNA in paraffin-embedded specimens of lupus vulgaris by polymerase-chain reaction. Arch Dermatol Res (1993) 0.86
Extracellular binding sites of IgA anti-jejunal antibodies on normal small bowel detected by indirect immunoelectronmicroscopy. J Invest Dermatol (1991) 0.86
Recombinant low-molecular-mass proteins pG and LA7 from Borrelia burgdorferi reveal low diagnostic sensitivity in an enzyme-linked immunosorbent assay. J Clin Microbiol (2001) 0.86
Molecular detection of Treponema pallidum in secondary and tertiary syphilis. Br J Dermatol (1997) 0.86
Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients. Melanoma Res (2002) 0.86
Treatment of systemic sclerosis with gamma-interferon. Br J Dermatol (1992) 0.86
Establishment of enzyme-linked immunosorbent assay using purified recombinant 83-kilodalton antigen of Borrelia burgdorferi sensu stricto and Borrelia afzelii for serodiagnosis of Lyme disease. J Clin Microbiol (1995) 0.86
Consensus statement on the safety profile of topical calcineurin inhibitors. Dermatology (2005) 0.86
Treatment of localised scleroderma with PUVA bath photochemotherapy. Lancet (1994) 0.86
Susceptibility of Neisseria gonorrhoeae to ceftizoxime in vitro and in vivo. Chemotherapy (1984) 0.86
Presence of herpes simplex virus DNA in erythema multiforme but not polymorphic light eruption. Br J Dermatol (2006) 0.86
Detection of herpes simplex virus in exacerbated pemphigus vulgaris by polymerase chain reaction. Dermatology (1996) 0.85
B-cell chronic lymphocytic leukemia associated with high serum IGE levels and pruriginous skin lesions: successful therapy with IFN-alpha 2b after failure on IFN-gamma. Dermatology (1996) 0.85